MRA Impact on Market Access
When CE Marking Is Sufficientβ
When MRA Chapter 4 is fully operational:
- CE-marked devices compliant with EU MDR/IVDR can generally be placed on the Swiss market with DAPI notification (not full registration)
- EU NB certificates are recognised by Swissmedic without separate technical review
- Technical documentation is not separately re-evaluated by Swissmedic
When Separate Swiss Registration Is Requiredβ
When MRA Chapter 4 is not fully operational:
- Full DAPI registration is required for Class IIa, IIb, III and IVD List A/B/Self-test
- Class I devices: DAPI notification within 30 days (same as when MRA is operational)
- EU MDR/IVDR NB certificates and DoC are used as the conformity evidence within the DAPI registration
Always Required β Regardless of MRA Statusβ
| Obligation | MRA Operational | MRA Not Operational |
|---|---|---|
| CH REP appointment | β Required | β Required |
| DAPI notification/registration | β Simplified | β Full registration |
| Swiss labelling (DE/FR/IT) | β Required | β Required |
| Vigilance reporting to Swissmedic | β Required | β Required |
| FSCA notification to Swissmedic | β Required | β Required |
Current MRA Statusβ
caution
Always verify the current MRA Chapter 4 operational status before planning your Swiss market access timeline. See MRA Status Updates and contact Swissmedic or SECO directly.
Disclaimer
AI-assisted navigation aid only. Always verify against official Swissmedic and Fedlex sources. Not legal or regulatory advice.